Skip to main content
. 2018 Jul;10(7):4169–4177. doi: 10.21037/jtd.2018.06.166

Figure 2.

Figure 2

EGFR mutation profiles determined by ARMS in ctDNA from chemotherapy-naive (A) and chemotherapy treated patients (B). EGFR, epidermal growth factor receptor; ARMS, amplification refractory mutation system; ctDNA, circulating free tumor-derived DNA.